Biovie Inc (BIVI)

NASDAQ
15.70
+0.18(+1.16%)
  • Volume:
    20,500
  • Bid/Ask:
    15.13/18.18
  • Day's Range:
    15.04 - 15.95

BIVI Overview

Prev. Close
15.52
Day's Range
15.04-15.95
Revenue
-
Open
15.73
52 wk Range
7.5-46.1
EPS
-11.87
Volume
20,500
Market Cap
350.63M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
2.2
1-Year Change
-1.88%
Shares Outstanding
22,333,324
Next Earnings Date
Sep 01, 2021
What is your sentiment on Biovie Inc?
or
Market is currently closed. Voting is open during market hours.

Biovie Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsBuyBuyNeutralNeutralSell
SummaryStrong BuyStrong BuyBuyNeutralSell

Biovie Inc Company Profile

Biovie Inc Company Profile

Employees
0

BioVie Inc. clinical-stage company pursuing the discovery, development, and commercialization of drug therapies for liver disease. The Company is focused on developing and commercializing BIV201 (continuous infusion terlipressin) an approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS). The Company is developing BIV201, a treatment option for patients suffering from ascites and other life-threatening complications of advanced liver cirrhosis caused by hepatitis, nonalcoholic steatohepatitis (NASH) and alcoholism. The Company is also engaged in developing NE3107, an ERK inhibitor that selectively reduces neuroinflammation and insulin resistance.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.